These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 19832688)

  • 21. Cannabis: pharmacology and toxicology in animals and humans.
    Adams IB; Martin BR
    Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
    Pertwee RG
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3353-63. PubMed ID: 23108552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabis and the brain.
    Iversen L
    Brain; 2003 Jun; 126(Pt 6):1252-70. PubMed ID: 12764049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioral effects of cannabinoid agents in animals.
    Chaperon F; Thiébot MH
    Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis and Neuropsychiatric Disorders: An Updated Review.
    Chayasirisobhon S
    Acta Neurol Taiwan; 2019 Jun; 28(2)():27-39. PubMed ID: 31867704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
    Shah SA; Gupta AS; Kumar P
    J Cancer Res Ther; 2021; 17(1):1-9. PubMed ID: 33723124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of the endocannabinoid system in the brain.
    Ramos JA; González S; Sagredo O; Gómez-Ruiz M; Fernández-Ruiz J
    Mini Rev Med Chem; 2005 Jul; 5(7):609-17. PubMed ID: 16026307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?
    Androvicova R; Horacek J; Stark T; Drago F; Micale V
    Pharmacol Res; 2017 Jan; 115():200-208. PubMed ID: 27884725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
    Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
    J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dark Classics in Chemical Neuroscience: Δ
    Banister SD; Arnold JC; Connor M; Glass M; McGregor IS
    ACS Chem Neurosci; 2019 May; 10(5):2160-2175. PubMed ID: 30689342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phytocannabinoids as novel therapeutic agents in CNS disorders.
    Hill AJ; Williams CM; Whalley BJ; Stephens GJ
    Pharmacol Ther; 2012 Jan; 133(1):79-97. PubMed ID: 21924288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focus on cannabinoids and synthetic cannabinoids.
    Le Boisselier R; Alexandre J; Lelong-Boulouard V; Debruyne D
    Clin Pharmacol Ther; 2017 Feb; 101(2):220-229. PubMed ID: 27861784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective.
    Cooper ZD; Craft RM
    Neuropsychopharmacology; 2018 Jan; 43(1):34-51. PubMed ID: 28811670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis: discrimination of "internal bliss"?
    Wiley JL
    Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis, Cannabinoids, and Cerebral Metabolism: Potential Applications in Stroke and Disorders of the Central Nervous System.
    Latorre JG; Schmidt EB
    Curr Cardiol Rep; 2015 Sep; 17(9):627. PubMed ID: 26238742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endocannabinoid system and the brain.
    Mechoulam R; Parker LA
    Annu Rev Psychol; 2013; 64():21-47. PubMed ID: 22804774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.
    Cooper ZD; Haney M
    Int Rev Psychiatry; 2009 Apr; 21(2):104-12. PubMed ID: 19367504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cannabinoids in the control of pain].
    Shaladi AM; Crestani F; Tartari S; Piva B
    Recenti Prog Med; 2008 Dec; 99(12):616-24. PubMed ID: 19388223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.